Juergen Hahn

Professor & Department Head, Biomedical Engineering Rensselaer Polytechnic Institute

  • Troy NY

Specializes in systems biology and process modeling and analysis with a focus on Autism diagnosis and treatment

Contact

Rensselaer Polytechnic Institute

View more experts managed by Rensselaer Polytechnic Institute

Spotlight

1 min

Big Data Offers New Insights Into Biological Components of Autism Spectrum Disorder

In recently published research, blood sample analysis showed that mothers of children with autism spectrum disorder (ASD) had several significantly different metabolite levels two to five years after they gave birth when compared to mothers of typically developing children. The research team behind this finding was Juergen Hahn, the head of the Department of Biomedical Engineering at Rensselaer Polytechnic Institute, a pioneer in the use of big data to investigate biological components of ASD. Hahn is available to discuss the findings of his recent research, as well as his overall approach to studying autism. Previously, Hahn discovered patterns with certain metabolites in the blood of children with autism that can be used to successfully predict diagnosis. He has since successfully applied his big data approach to evaluating potential ASD treatments. For the recent paper, which Hahn co-authored, his team analyzed blood samples from 30 mothers whose young children had been diagnosed with ASD and 29 mothers of typically developing children. They found differences in several metabolite levels between the two groups of mothers. While the samples analyzed were taken two to five years after pregnancy, these research findings raise the question of whether or not the differences in metabolites may have been present during pregnancy as well. In addition to his specific findings, Hahn is available to discuss the use of big data in improving society's understanding of the biological mechanisms at work in ASD.

Juergen Hahn

Areas of Expertise

Computational Systems Biology
Data Science
Autism Spectrum Disorder
Modeling and Control

Biography

Juergen Hahn is professor and head of the Department of Biomedical Engineering and holds an appointment in the Department of Chemical and Biological Engineering. Hahn’s research interests include systems biology and process modeling and analysis, with over 140 peer-reviewed publications in print.
Hahn received a Fulbright scholarship (1995-96), the Best Referee Award 2004 from the Journal of Process Control, and the CPC 7 Outstanding Contributed Paper Award in 2006. He was named Outstanding Reviewer by the journal Automatica in 2005, 2006, and 2007. Hahn was the 2010 CAST Outstanding Young Researcher. He was elected as an AIMBE fellow in 2013, an AIChE fellow in 2020, and a fellow of BMES in 2022. He served on the IEEE CSS Board of Governors in 2016 and has been a CACHE Trustee since 2014. He is currently serving as deputy editor-in-chief for the Journal of Process Control and as associate editor for Control Engineering Practice, Journal of Advanced Manufacturing and Processing, and Journal of Personalized Medicine.
Hahn earned his bachelor’s degree in engineering from RWTH Aachen, Germany, in 1997. He earned his master’s and doctoral degrees in chemical engineering from the University of Texas, Austin, in 1998 and 2002, respectively. He was a post-doctoral researcher at the Chair for Process Systems Engineering at RWTH Aachen, Germany, before joining the Department of Chemical Engineering at Texas A&M University, College Station, in 2003. Hahn has been with Rensselaer since 2012.

Education

University of Texas at Austin

Ph.D.

Chemical Engineering

2002

University of Texas at Austin

M.S.

Chemical Engineering

1998

RWTH Aachen, Germany

Diploma Degree

Engineering

1997

Media Appearances

New Blood Test Could Revolutionize Autism Diagnosis

Verywell Health  online

2020-09-03

The current method of diagnosing the disorder “is purely observational, which makes it time-consuming,” lead study author Juergen Hahn, PhD, a professor and head of the Department of Biomedical Engineering at Rensselaer Polytechnic Institute, tells Verywell. “One result of this is while ASD can be diagnosed by 18 to 24 months, the average age of diagnosis is around four years of age. There is often a long waiting period involved between when concerns regarding ASD are noted and when an actual diagnostic observation is scheduled."

View More

Medical conditions may mark distinct autism subtypes

Spectrum  online

2019-07-04

An autistic child in one group generally has few conditions that overlap with those of a child in a different group, says lead researcher Juergen Hahn, professor of biomedical engineering at Rensselaer Polytechnic Institute in Troy, New York.

View More

Using Big Data To Evaluate Autism Treatments

The Academic Minute  online

2019-05-09

Juergen Hahn is the department head of the Department of Biomedical Engineering at Rensselaer Polytechnic Institute in addition to holding an appointment in the Department of Chemical & Biological Engineering. He received his Diploma degree in engineering from RWTH Aachen, Germany, in 1997, and his MS and Ph.D. degrees in chemical engineering from the University of Texas, Austin, in 1998 and 2002, respectively.

View More

Show All +

Articles

Maternal risk factors vary between subpopulations of children with autism spectrum disorder

Autism Research

Genevieve Grivas, Richard E Frye, Juergen Hahn

2022

Previous work identified three subgroups of children with ASD based upon co-occurring conditions (COCs) diagnosed during the first 5 years of life. This work examines prenatal risk factors, given by maternal medical claims, for each of the three subgroups: children with a High-Prevalence of COCs, children with mainly developmental delay and seizures (DD/Seizure COCs), and children with a Low-Prevalence of COCs. While some risk factors are shared by all three subgroups, the majority of the factors identified for each subgroup were unique; infections, anti-inflammatory and other complex medications were associated with the High-Prevalence COCs group; immune deregulatory conditions such as asthma and joint disorders were associated with the DD/Seizure COCs group; and overall pregnancy complications were associated with the Low-Prevalence COCs group. Thus, we have found that the previously identified subgroups of children with ASD have distinct associated prenatal risk factors. As such, this work supports subgrouping children with ASD based upon COCs, which may provide a framework for elucidating some of the heterogeneity associated with ASD.

View more

Towards a Multivariate Biomarker-Based Diagnosis of Autism Spectrum Disorder: Review and Discussion of Recent Advancements

Seminars in Pediatric Neurology

Troy Vargason, Genevieve Grivas, Kathryn L Hollowood-Jones, Juergen Hahn

2020

An ever-evolving understanding of autism spectrum disorder (ASD) pathophysiology necessitates that diagnostic standards also evolve from being observation-based to include quantifiable clinical measurements. The multisystem nature of ASD motivates the use of multivariate methods of statistical analysis over common univariate approaches for discovering clinical biomarkers relevant to this goal. In addition to characterization of important behavioral patterns for improving current diagnostic instruments, multivariate analyses to date have allowed for thorough investigation of neuroimaging-based, genetic, and metabolic abnormalities in individuals with ASD. This review highlights current research using multivariate statistical analyses to quantify the value of these behavioral and physiological markers for ASD diagnosis. A detailed discussion of a blood-based diagnostic test for ASD using specific metabolite concentrations is also provided. The advancement of ASD biomarker research promises to provide earlier and more accurate diagnoses of the disorder.

View more

Clustering of co-occurring conditions in autism spectrum disorder during early childhood: A retrospective analysis of medical claims data

Autism Research

Troy Vargason, Richard E Frye, Deborah L McGuinness, Juergen Hahn

2019

Individuals with autism spectrum disorder (ASD) are frequently affected by co-occurring medical conditions (COCs), which vary in severity, age of onset, and pathophysiological characteristics. The presence of COCs contributes to significant heterogeneity in the clinical presentation of ASD between individuals and a better understanding of COCs may offer greater insight into the etiology of ASD in specific subgroups while also providing guidance for diagnostic and treatment protocols. This study retrospectively analyzed medical claims data from a private United States health plan between years 2000 and 2015 to investigate patterns of COC diagnoses in a cohort of 3,278 children with ASD throughout their first 5 years of enrollment compared to 279,693 children from the general population without ASD diagnoses (POP cohort).

View more

Show All +